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Mature autogenous fistulas (AF) for hemodialy-
sis are associated with improved patency rates and
reduced infection rates compared with synthetic
bridging grafts (BGs).1-5 AFs, however, have higher
early failure rates than BGs, and use of AFs in the
United States has declined, whereas use of BGs has
increased.1-6 The inability to predict adequacy of
venous outflow solely on clinical examination and
the use of suboptimal veins and arteries may have
contributed to higher early failure rates for AFs and
the increased use of BGs.
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Purpose: We studied the efficacy of preoperative noninvasive assessment of the upper
extremity to identify arteries and veins suitable for hemodialysis access to increase our
use of autogenous fistulas (AF).
Methods: From Sep. 1, 1994, to Apr. 1, 1997, 172 patients who required chronic
hemodialysis underwent segmental upper extremity Doppler pressures and duplex ultra-
sound with mapping of arteries and veins. The following criteria were necessary for sat-
isfactory arterial inflow: absence of a pressure gradient between arms, patent palmar
arch, and arterial lumen diameter 2.0 mm or more. The criteria necessary for satisfacto-
ry venous outflow were venous luminal diameter greater than or equal to 2.5 mm for
AF and greater than or equal to 4.0 mm for synthetic bridging grafts (BG) and conti-
nuity with distal superficial veins in the arm. Intraoperative and duplex ultrasound mea-
surements were compared. Contemporary experience was compared with the 2-year peri-
od (1992 to 1994) before implementation of the protocol.
Results: During the period from Sep. 1, 1994, to Apr. 1, 1997, 108 patients (63%) had
AF, 52 (30%) had prosthetic BG, and 12 (7%) had permanent catheters (PC) placed.
Early failure was seen in 8.3% of AFs. Primary cumulative patency rates were 83% for AF
and 74% for BG at 1 year (p < 0.05), with a mean clinical follow-up of 15.2 months. No
postoperative infections were observed with AF, whereas six infections (12%) were
observed with BG and two (17%) with PC insertion. During the period from June 1,
1992, to Aug. 31, 1994, 183 procedures were performed with a distribution of 14% AF,
62% BG, and 24% PC. In this earlier period the AF early failure rate was 36%, and the
patency rates were 48%, 63%, and 48% for AF, BG, and PC, respectively (mean follow-
up, 13.8 months).
Conclusion: A protocol of noninvasive assessment increased use of AFs. The cumulative
patency rate of AFs was improved, and early failure rates were reduced when compared
with the preceding institutional experience. Routine noninvasive assessment is recom-
mended to document adequacy of arterial inflow and delineate venous outflow to max-
imize opportunities for AF. (J Vasc Surg 1998;27:302-8.)
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We report our experience with preoperative non-
invasive assessment of the upper extremity to better
identify arteries and veins suitable for hemodialysis
access. We hypothesized that such a strategy would
increase our options for AF by identifying veins that
were not clinically evident, thereby reducing the AF
early failure rate by improved selection. This strategy
was developed to increase the use of AFs, enhance
the cumulative patency rate, and maximize options
for hemodialysis access in our dialysis population.
PATIENTS AND METHODS
Since September of 1994, all patients who were
referred for hemodialysis access procedures at our
institution were entered into a dialysis access reg-
istry. Demographic information and medical history
were obtained and recorded in a prospective man-
ner. All patients underwent preoperative evaluation
by duplex ultrasound (DU) to assess the suitability
of upper extremity arteries and veins and to facilitate
planning of dialysis access. Table I summarizes crite-
ria that were used to define satisfactory venous out-
flow and arterial inflow. In addition, suitability of
upper extremity arteries and veins for AF was evalu-
ated by clinical examination in all cases by the oper-
ating surgeon before noninvasive evaluation and
recorded separately for later comparisons.
From September 1994 to January 1997, 172
patients were evaluated. The patients were 60% men
and 40% women. The mean age of the patients was
63.3 years, with a range of 25 to 82 years. The caus-
es of end-stage renal disease and the incidence rates
were 36% for hypertension, 31% for diabetes melli-
tus, 12% for glomerulonephritis, 4% for HIV-related
nephropathy, and 17% for other causes.
Ultrasound technique. Ultrasound scans of the
superficial venous system were initiated at the wrist of
the nondominant arm with a tourniquet placed at mid-
forearm. Superficial veins in the forearms were dilated
by tapping and stroking maneuvers. Warm ultrasound
gel (Thermasonic, Parker Labs, Orange, N.J.) was
applied, and the veins were insonated with a 5 MHz or
7 MHz scanning probe (Accuson, 128 XP-10
Mountain View, Calif.). Veins were assessed for com-
pressibility and diameter. The tourniquet  was moved
to the arm, and forearm veins with acceptable diame-
ters were followed proximally for continuity and size.
At the antecubital space, continuity with arm veins was
verified. The tourniquet  was removed, and continuity
of the deep system was determined through the axillary
and subclavian veins. The superficial forearm veins that
were most suitable, as identified by DU, were mapped
by skin markings for the operative procedure.
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When the venous anatomy was acceptable for an
AF, segmental arterial pressures were measured, and
the status of the radial artery was evaluated. The
diameter of the radial artery at the wrist was mea-
sured, and the radial artery was scanned by DU. The
patency of the palmar arch was verified. If the radial
artery was not suitable, the ulnar and brachial arter-
ies were examined as possible alternative sources of
arterial inflow. Evaluation of the dominant arm was
performed only when the nondominant arm evalua-
tion was unsatisfactory. Skin that was overlying the
most suitable segment of artery was marked.
Patients who required immediate dialysis and yet
were noted to have suitable arteries and veins for AF
formation were evaluated for concomitant place-
ment of a contralateral internal jugular hemodialysis
catheter for use during the maturation period. AFs
were allowed a period of 4 to 6 weeks for maturation
before attempts at cannulation. AFs were evaluated
by DU before initial access, and the areas of maximal
diameter were marked on the skin to facilitate nee-
dle cannulation by dialysis nursing personnel.
Access procedures were performed on an outpa-
tient basis with the same-day surgery unit. Intra-
operative measurements of arterial and venous
diameters were performed with intravascular dilators
to evaluate the accuracy of preoperative DU mea-
surements.
BG procedures were performed with 6 mm poly-
tetrafluoroethylene grafts as either forearm antecu-
bital loop grafts or upper arm brachial-axillary grafts.
If both anatomic locations were acceptable, the fore-
arm loop was used preferentially in all cases.
A successful AF or BG remained patent and sus-
tained a velocity of blood flow (‡ 250 ml/sec) that
was sufficient for successful hemodialysis. AFs or
BGs that thrombosed before initiation of dialysis
were considered early failures. In addition, AFs that
remained patent but failed to mature sufficiently to
Table I. Noninvasive criteria for selection of upper
extremity arteries and veins for dialysis access pro-
cedures
Venous Examination
Venous luminal diameter ‡ 2.5 mm for AF
Venous luminal diameter ‡ 4.0 mm for BG
Absence of segmental stenoses or occluded segments
Continuity with the deep venous system in the upper arm
Absence of ipsilateral central venous stenosis or occlusion
Arterial Examination
Absence of pressure differential ‡ 20 mm Hg between arms
Arterial lumen diameter ‡ 2.0 mm
Patent palmar arch
allow successful needle cannulation and provide flow
rates adequate for dialysis were considered as failures
for determination of life table cumulative patency
rates. DU was performed at 3-month intervals or as
indicated by flow rates (≤250 ml/sec) during dialy-
sis, increased venous return pressures, or difficulty
during attempted cannulation.
The records of 183 patients who underwent
access procedures at our institution from June 1,
1992, to August 31, 1994, before the initiation of
this protocol were reviewed to evaluate the impact
on the choice of dialysis access procedures. The inci-
dence of each procedure’s use was recorded and
compared between the two periods of observation.
Statistical analysis. Apparent differences in the
frequency of various procedures for hemodialysis were
analyzed for statistical significance with c 2 analysis and
Fisher’s exact test. The fraction represented by each
procedure was evaluated during the two time periods
with a normal approximation z test for proportions.
Differences were significant when the p value was less
than 0.05. The cumulative patency rates for AFs and
BGs performed on the 172 patients that were evalu-
ated with our DU protocol were determined and
compared with life table analysis.
RESULTS
Of the 172 patients evaluated by DU, 108 (63%)
had arteries and veins suitable for AF, 52 patients (30%)
were suitable for BG, and 12 patients (7%) underwent
placement of permacaths (PCs). The early failure rate
was 8.3% (nine of 108) for AF and 7.6% (four of 52)
for BG. Clinical follow-up by repeat DU (mean, 15.2
months) confirmed primary cumulative patency rates
for AFs of 83% and 73% at 12 and 21 months, respec-
tively (Table II). Primary cumulative patency rates for
BGs were 74% and 62% at the same time intervals
(Table III). The number of PCs was inadequate for life
table analysis, but during the follow-up period seven of
the 12 PCs failed, for an absolute patency rate of 42%.
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Table II. Life table analysis of cumulative primary patency rates for autogenous fistula
No. at risk at No. of No. withdrawn Interval Cumulative
Interval (mo) start of interval failures patent patency rate patency SE (%)
0-1 108 4 0 0.96 100 0.00
1-3 104 5 10 0.95 96 1.88
3-6 89 2 11 0.98 91 2.89
6-9 76 3 8 0.96 89 3.39
9-12 65 1 9 0.98 85 4.08
12-15 55 2 10 0.96 83 4.61
15-18 43 2 12 0.95 80 5.45
18-21 29 1 8 0.96 76 6.91
21-24 20 1 6 0.94 73 8.48
24-27 13 0 7 1.00 69 10.65
27-30 6 0 5 1.00 69 15.68
30-33 1 0 1 1.00 69 38.41
SE, Standard error.
Table III. Life table analysis of cumulative primary patency rates for bridging grafts
No. at risk at No. of No. withdrawn Interval Cumulative
Interval (mo) start of interval failures patent patency rate patency SE (%)
0-1 52 2 0 0.96 100 0
1-3 50 2 2 0.96 96 2.72
3-6 46 3 3 0.93 92 3.84
6-9 40 3 4 0.92 86 5.08
9-12 33 2 3 0.94 79 6.30
12-15 28 1 4 0.96 74 7.13
15-18 23 1 4 0.94 71 7.97
18-21 18 1 1 0.94 66 9.07
21-24 16 1 2 0.93 62 9.55
24-27 13 1 6 0.90 58 10.42
27-30 6 1 3 0.78 52 14.70
30-33 2 0 2 1.0 40 21.90
SE, Standard error.
Table IV compares the relative frequencies of
each access type performed during the two time
periods. During the period before implementation
of the protocol, June 1, 1992, to August 31, 1994,
183 procedures were performed with the following
distribution: 25 AF (14%), 114 BG (62%) and 44
PC (24%). The AF early failure rate during this peri-
od was 38% (10 of 25), and the BG early failure rate
was 11% (13 of 114). Patency rates of 48%, 63%, and
48% were obtained for AFs, BGs, and PCs, respec-
tively (mean follow-up, 13.8 months). Populations
from two time periods were compared. No differ-
ences were seen in the male-to-female patient distri-
bution, the mean age of patients treated, or causes of
end-stage renal disease.
Comparisons between the two periods showed
significant differences in usage rates of AFs, BGs,
and PCs (p < 0.05). Early failure rates were signif-
icantly lower for AFs during the period that used
the noninvasive protocol as compared with the
previous period (p < 0.05). In addition, compar-
isons of patency rates by access type also showed a
significant increase in patency rates for AFs and
BGs performed during the protocol period (p <
0.05). PC patency rates were comparable in the
two periods.
The accuracy of DU measurements compared
with intraoperative findings was 98%. In only three
instances, veins that were measured as 2.5 mm by
DU were found to have internal lumens of less than
2 mm at operation and were not used.
Of the 108 AF cases, 57 (53%) were performed
in forearms that did not appear clinically suitable for
AFs when visually inspected by the surgeon before
ultrasound mapping. Sixteen of the 108 procedures
were radiocephalic fistulas that could be performed
through a single incision. The remaining 92 fistulas
were performed with separate incisions for arteries
and veins with transposition of superficial veins to
subcutaneous tunnels.
Table V compares dialysis unit census records for
the two periods. Of the 60 patients who were under-
going chronic hemodialysis in June 1994 before ini-
tiation of our protocol, five (8%) were being dia-
lyzed by AF, 39 (65%) by BG, and 16 (27%) by PC.
In April 1997, at the end of our study period, of 64
patients who were undergoing chronic hemodialysis,
41 (64%) were being dialyzed by AFs, 19 (30%) by
BGs, and four (6%) by permanent catheters, which
represented a significant (p < 0.01) increase in the
use of AF.
No postoperative infections were observed with
AFs, but six were seen with BG, and two were seen
with PC insertion. Symptomatic steal was observed
in one BG, and no symptomatic steal was observed
with AFs. Pseudoaneurysm developed in two BGs.
One AF developed diffuse aneurysmal dilitation with
maximal diameters of 2.0 cm but continues to func-
tion successfully more than 2 years after placement.
DISCUSSION
Surgical procedures for hemodialysis access are
the most common vascular surgical operations in the
United States, and vascular surgeons were responsi-
ble for 72% of the procedures in 1992.7 For general
surgeons, the hemodialysis access procedure was the
most common vascular surgical procedure.8 The
importance and impact of this procedure are high-
lighted by the observations that more than 200,000
Americans are dialysis-dependent and more than
$9.5 billion are spent annually on the treatment of
end-stage renal disease (ESRD).6
A review of data from the United States Renal
Data System’s 1995 Annual Report6 shows that
patient characteristics and hemodialysis access place-
ment patterns have changed significantly since the
initial description of successful hemodialysis by the
autogenous radiocephalic fistula.9 The average age
of patients entering dialysis has increased, and
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Table IV. Relative frequencies of each access type
placed during the two periods
Before institution Noninvasive
of protocol protocol
Autogenous fistula* 14% 63%
Bridging grafts 62% 30%
Permanent catheter 24% 7%
Prevalence significantly different in each group (p < 0.05). From
June 1992 to August 1994, 183 procedures were performed
before institution of protocol. From September 1994 to April
1996, 172 procedures were performed with noninvasive proto-
col.
Table V. Impact of protocol on patient access pro-
file from in-hospital dialysis unit census records
Before protocol After protocol
(June 1994; (April 1997;
n = 60) n = 64)
Dialysis accomplished by:
AF 8% 64%
BG 65% 30%
PC 27% 6%
Differences are significant for each access type (p < 0.05).
patients now arrive for hemodialysis access in more
debilitated states with additional comorbid condi-
tions. Life expectancy on dialysis, however, is
increasing, whereas hemodialysis access patency rates
remain so poor that each patient who undergoes
dialysis may require numerous access procedures and
revisions during their dialysis lifetime. The average
yearly cost per patient with ESRD to the Medicare
system is in excess of $50,000. A significant portion
of these costs is for dialysis access procedures. Poor
patency rates for hemodialysis access procedures
contribute to these costs by requiring revisions and
new procedures. These factors underscore the value
of the strategy outlined in this report, which results
in greater use of AFs, with their associated improved
patency rate and reduced rate of complications.
Three common procedures that are performed
for hemodialysis access are AF, prosthetic BG, and
indwelling central venous catheters. Use of AFs, ini-
tially regarded as the preferred option for hemodial-
ysis access, has become less prevalent as performance
of BGs has increased. The most recent available
data6 confirmed that prosthetic BGs were used 1.7
times more than AFs (51.9% for BGs vs. 30.5% for
AFs and 9.3% for PCs).6
The radiocephalic fistula, as performed through
a single incision, became the preferred method for
hemodialysis access after its initial description in
1966.9 However, changing patient profiles in the
last 30 years have contributed to a decrease in the
performance of AFs. In more debilitated older
patients with ESRD who arrive for hemodialysis
today, arteries and veins in close proximity, suitable
for radiocephalic fistulas, are uncommon. In addi-
tion, as presented in our series, visual inspection and
physical examination of upper extremities are often
inadequate for the identification of suitable arteries
and veins. Only 16 of the 108 patients were candi-
dates for radiocephalic fistulas as performed through
a single incision, and preparative physical examina-
tion alone of the upper extremity failed to identify
suitable veins for AF in 58 of the 108 cases.
Several authors have reported higher patency
rates for BGs than for AFs10 because of the higher
early failure rates for AFs. AF includes procedures
that remain patent but fail to mature sufficiently to
support dialysis. In many cases, these failures may be
attributed to the difficulty in selecting adequate
veins for AF by clinical examination alone, as con-
firmed by our series. Use of preoperative assessment
by DU reduces early failures significantly and corre-
lates with the improved patency rates and decreased
rates of infection reported for mature AFs as com-
pared with BGs.1-5 Because of the location in the
forearm, the goal of preservation of more proximal
vasculature for future hemodialysis access proce-
dures is accomplished.
Duplex ultrasound has been used effectively to
map lower extremity arteries and veins for infrain-
guinal bypass procedures and for surveillance of
infrainguinal vein grafts.11,12 We have used DU in
the upper extremity for selection of patients for AF
hemoaccess and for clinical follow-up of patients
undergoing hemodialysis access procedures. DU has
enhanced our ability to identify arteries and veins
suitable for AFs. In addition to selection of patients
for radiocephalic fistulas, a larger group of patients
has been selected for superficial venous transposition
in the forearm, recently described by our group.13
Separate incisions are used for exploration and
mobilization of the artery and vein. The vein then is
transposed to a subcutaneous tunnel along the volar
aspect of the forearm and anastamosed to the appro-
priate artery. Ninety-two of the 108 AFs in this
series were performed with superficial venous trans-
position.
If arteries and veins that are suitable for AF are
not identified, options for BG are considered. We
have used either the forearm antecubital loop graft or
the upper arm brachial-axillary straight prosthesis for
BG. We agree with other authors that the forearm
loop graft should be used initially to preserve the
option of a later brachial-axillary graft placement.
In our series, the use of AFs has increased signif-
icantly as a result of preoperative noninvasive evalu-
ation of the upper extremity. Early failure rates for
AFs were significantly reduced from 36% before
implementation of the protocol to 8.3% in our cur-
rent experience. Patency rates for AFs and BGs also
have improved significantly. In addition, reduced
infection rates for AF also support our recommen-
dation for the preferential use of AF.
Our recent strategy for management of patients
who are dialysis-dependent has altered procedures
for hemodialysis access. Since the introduction of a
preoperative noninvasive protocol, we have signifi-
cantly increased use of AFs. Currently, 64% of our
patients undergo successful hemodialysis with AFs.
We recommend adoption of this protocol to maxi-
mize use of AFs, thereby reducing dependency on
BGs and PCs.
The authors would like to acknowledge the important
contributions of Dr. Robert P. Davis to this field of study.
Dr. Silva dedicates this work to the memory of this con-
summate gentleman and surgical mentor.
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Dr. Julie Ann Freischlag (Milwaukee, Wis.). The paper
presented by Dr. Silva outlines a preoperative strategy that
allowed improvement in success with autogenous fistulas
and synthetic bridge graft fistulas. Their 1-year patency
rates of 83% for the autogenous fistulas and 74% for syn-
thetic bridge fistulas are impressive. The very low early
failure rate of 8.3% in their autogenous fistulas is also most
impressive. I have three questions.
First, what is the cost for this preoperative duplex scan,
and how long does this procedure take? Do you really
need to scan the arteries of these patients who have sym-
metric blood pressures and a palpable radial pulse?
Second, what is your protocol for the early failures, the
autogenous fistulas that do not mature, and also for the
late failures in this group of patients? Do you perform a
new graft, or do you use any salvage procedures such as
urokinase or thrombectomy in these patients?
Third, in your manuscript you state that you follow up
your grafts every 3 months with duplex scanning to detect
abnormalities. What significant abnormalities are you find-
ing? How do you proceed if you do find an abnormality in
these grafts? Does the procedure depend on whether the
graft is autogenous or whether the graft is a synthetic
bridge graft fistula?
Dr. Michael B. Silva, Jr. I understand that the cost of
the procedure is from $300 to $400. The time of the pro-
cedure is about 30 minutes. This time and expense can be
criticized, but even a small reduction in failure rates for
either autogenous fistulas or bridging grafts would result
in an enormous savings to the annual expenditure. This
result is evident from the early data I presented about the
annual expenditures of the Medicare system on dialysis
access. So we can justify this strategy that has clearly
improved our fistula patency rates and early failure rates on
the basis of cost alone.
A number of the fistulas that failed early developed
stenoses within the arterialized vein segment. Four of the
19 fistulas were identified during the initial duplex scan as
being patent but having problems. These were revised. We
have not had much success revising thrombosed arteriove-
nous fistulas, although we have tried both surgical and
lytic therapy options.
We are accumulating data for the duplex ultrasound
criteria that would suggest an impending failure in both
the autogenous fistulas and the bridging grafts. More
importantly, we have instituted weekly rounding in the
dialysis unit, we look at pressures on dialysis, and we talk
to the nurses who access the fistulas, and that is probably
our most effective method of identifying grafts that are
problematic. Those patients then are evaluated with
duplex ultrasound. We have found a number of problems
that can be addressed before the fistula goes on to throm-
bose.
Dr. Kaj H. Johansen (Seattle, Wash.). This paper is
extremely useful because it offers us the opportunity to
understand the natural history of this most common vas-
cular procedure. I say “opportunity” because, in my expe-
rience, I do not believe you have addressed the real prob-
lem. The real problem is not graft patency but rather mat-
uration of these fistulas to the extent that they actually can
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DISCUSSION
Dr. Silva. An integral portion of the examination is the
assessment of the axillosubclavian runoff. If a patient has
evidence of subclavian vein stenosis, we will look toward
the other upper extremity. If a patient has a good option
for an autogenous fistula and has proximal venous steno-
sis, we do not use that as complete exclusion criteria, and
we will attempt an autogenous fistula. We have had some
success with the creation of autogenous fistulas distal to a
proximal stenosis, but we optimally will select the con-
tralateral extremity if possible.
Dr. J. Dennis Baker (Los Angeles, Calif.). A large per-
centage of your second series were transposed veins. Do
you find increased complication rates for strictures and
other complications in the transposed segments compared
with the traditional Brecia-Cimino type operation?
An important realization is that most Medicare carri-
ers will not pay for this duplex scanning because it is not
an accepted indication. Publishing the results of similar
series will be important to establish the medical necessity
of the preoperative examination. Publication is best to
convince the carriers to modify payment policies.
Dr. Silva. To answer your first question, the duplex scan
is aimed at identifying areas within the vein that will
become problematic later. So we selectively choose a vein
that begins, perhaps, as a cephalic, then crosses through
the median cubital and becomes a portion of the basilic.
This choice is one reason that we rely on transposition and
that these patients may have somewhat convoluted inci-
sions. However, with this procedure, we have reduced the
incidence of problems from venous stricture in the post-
operative period, and we have seen no increase in compli-
cation rates from this technique.
The second issue you address is critical both for the
preoperative noninvasive assessment and perhaps for this
relatively new procedure. A superficial venous transposi-
tion can be coded slightly differently than an autoge-
nous radiocephalic fistula. However, as you know, the
reimbursement rates for this procedure are based on the
primary arteriovenous fistula, which is much less than
for bridging grafts. Whereas those rates were initially
based on the amount of time taken for the procedure,
the amount of time taken for superficial venous trans-
position is substantially increased in a simple radio-
cephalic procedure performed through a single incision.
So our leaders in the vascular community need to
address both of those issues with the Medicare system to
perhaps redefine superficial venous transposition as a
different type of access procedure and, again, to under-
line the importance of preoperative assessment in saving
dollars down the road.
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be accessed by dialysis personnel. Do you have vascular
laboratory criteria that suggest which fistulas were going
to mature or not in 1 year?
Dr. Silva. You are right in your assertion that to
improve the long-term patency rate of autogenous fistulas
we must address the issue of maturation as we have done
in this study. The early failure rate was 38% in the group
studied previously, before the institution of the protocol,
which includes fistulas that did not mature. With the
enhancing ability of the noninvasive laboratory to identify
suitable veins and arteries, we have decreased that failure-
to-mature rate to 8.3%. We have done that through
improving selection and improving the qualities of the
veins that are identified and by increasing our options for
identifying suitable veins by using veins that are remote
from the arterial inflow source. We continue to accumu-
late data both before and after surgery that might have
some predictive value for veins that tend to thrombose.
Dr. Albert G. Hakaim (Boston, Mass.). I have a ques-
tion that is a follow-up to the previous question. We have
been very aggressive in using autogenous conduits for fis-
tulas, and we have reported that, in patients who are dia-
betic, forearm Cimino-Brescia fistulas have a very high
nonmaturation rate. They have a thrill, but the veins do
not mature. Although we have not conducted noninvasive
studies, I wondered whether you have looked at patients
with diabetes as a separate subgroup and whether the
degree of calcification in the vessels is correlated with early
nonmaturation?
Dr. Silva. That is correct. The United States Renal Data
Service, in the report that I referenced early in this talk,
said that, by review of their records, the autogenous fistu-
la was not cost-effective in patients with diabetes because
of a decreased long-term patency rate. In fact, they noted
the increased prevalence of bridging grafts in patients who
have diabetes. This finding also speaks to Dr. Freischlag’s
question of using the duplex scan to assess the arteries. We
looked for segments of arteries without significant calcifi-
cation and would modify our arterial anastomosis on the
basis of that examination.
Dr. Roger M. Hayashi (San Jose, Calif.). With the
increasing use of veno-venodialysis from a percutaneous
route, we have found that a growing percentage of our
patients develop central venous hypertension from subcla-
vian venous stenosis. Have you been able to predict this
development with your noninvasive evaluation? If you find
evidence for central venous hypertension, would that alter
your management for primary access?
